Trial · NCT04213261
Adverse events14
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 14 of 14
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Tachycardia | Cardiac disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| other | Injection site pain | General disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 2 |
| other | Growth retardation | Musculoskeletal and connective tissue disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| other | Osteoporosis | Musculoskeletal and connective tissue disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| other | Pruritus | Skin and subcutaneous tissue disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| other | Superficial vein thrombosis | Vascular disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| other | Injection site haemorrhage | General disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| other | Injection site swelling | General disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| other | COVID-19 | Infections and infestations | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| other | Skin infection | Infections and infestations | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| other | Wound infection | Infections and infestations | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| serious | Lower limb fracture | Injury, poisoning and procedural complications | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| serious | Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
| serious | Pulmonary infarction | Respiratory, thoracic and mediastinal disorders | FCX-007 COL7A1 Genetically-Corrected Autologous Fibroblasts | 1 | 6 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04213261/events